Inhibikase Therapeutics Stock (IKT)

Track Inhibikase Therapeutics stock through TheStreet Pro's latest coverage, including articles, Daily Diary mentions, Action Alerts PLUS portfolio activity, contributor watchlist signals, and Pro price levels.

$1.76
▼ -0.07 (-3.95%) past year
$1.40$1.60$1.80$2.00$2.20May '25Aug '25Oct '25Dec '25Mar '26May '26
Market Cap
$224.46M
P/E Ratio
—
1Y Return
-3.95%
EPS (TTM)
-$0.43

Read the latest TheStreet Pro articles mentioning Inhibikase Therapeutics, including market roundups, portfolio updates, trade ideas, and investing analysis.

Articles

0 articles

No articles mentioning IKT yet.

Daily Diary Mentions

0 mentions

No diary mentions for IKT yet.